Abstract:Bioactive peptides produced from natural sources are considered as strategic target for drug discovery. Hyperglycemia caused protein glycation alters the structure of many tissues that impairs their functions and lead complications diseases in human body. This study investigated the bioactive peptides produced from red and brown Lens culinaris that might inhibit protein glycation to prevent diabetic complications. In this study, red and brown Lens culinaris protein hydrolysates were prepared by tryptic digestion, using an enzyme/substrate ratio of 1:20 (g/g), at 37°C, 12 hr then peptide fractions <3 kDa were filtered by using ultrafiltration membranes. Protective ability against protein glycation, DPPH radical scavenging, and anti-proliferative activities (on HepG2, MCF-7, and PC3 cell lines) of peptide fractions were assayed in vitro. Results showed that glycation was inhibited by peptides from 28.1% to 68.3% in different test model. PC3 cell line was more sensitive to the peptides which showed strong anticancer activity with lower IC50 (0.96 mg/ml). Peptide fractions were sequenced by HPLC-MS-MS. Twenty eight novel peptides sequences was identified. In silico study, two peptides could be developed as a potential bioactive peptides exhibited antiglycation, antioxidant, and antiproliferative activities. PRACTICAL APPLICATIONS: Peptides are becoming an emerging source of medications with the development of new technologies. We have selected Lens Culinaris as one of the rich sources of proteins to explore novel bioactive peptides encapsulated in its seeds. Peptides fractions demonstrated protective ability against protein glycation, strong antioxidant potential, and promising antiproliferative activity. We have identified 28 novel peptides and molecular docking study revealed that some peptides showed strong binding potential to insulin receptor and ACE. Thus, these peptides might be used to manage diabetes complication as well as COVID-19 disease due to their interaction with ACE. However, those peptides needs to be further studied as a potential new drug.

Inhibition of ascorbic acid-induced modifications in lens proteins by peptides

Isolation and characterization of a new advanced glycation endproduct of dehydroascorbic acid and lysine

2-Ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (Op-Lysine) is a Newly Identified Advanced Glycation End Product in Cataractous and Aged Human Lenses

Natural dipeptides as mini-chaperones: molecular mechanism of inhibition of lens βL-crystallin aggregation

Inhibitory Effects of Hydroxysafflor Yellow A on the Formation of Advanced Glycation End Products in Vitro.

The effect of diabetes and dietary ascorbate supplementation on the oxidative modification of rat lens beta L crystallin

Comparison of Protective Effects of Phenolic Acids on Protein Glycation of BSA Supported by In Vitro and Docking Studies

Ascorbic acid mediated alteration of alpha-crystallin secondary structure

Aspartic acid functions as carbonyl trapper to inhibit the formation of advanced glycation end products by chemical chaperone activity

Inhibitory Potential of Carnosine and Aminoguanidine Towards Glycation and Fibrillation of Albumin: In-vitro and Simulation Studies

Identification, protein antiglycation, antioxidant, antiproliferative, and molecular docking of novel bioactive peptides produced from hydrolysis of Lens culinaris

Inhibition of Highland Barley Bran-Derived Carbon Dots on the Formation of Advanced Glycation End Products

Butein Inhibits the Glycation of α-Crystallin: An Approach in Prevention of Retinopathy

[Muscle dipeptides--natural inhibitors of lipid peroxidation]

Protocatechualdehyde Prevents Methylglyoxal-Induced Mitochondrial Dysfunction and AGEs-RAGE Axis Activation in Human Lens Epithelial Cells.

Dihydroasparagusic acid: antioxidant and tyrosinase inhibitory activities and improved synthesis

[Chaperon-like anticataract agents, the antiaggregants of lens crystallin. Communication 4. Study of the effect of a mixture of di- and tetrapeptides on a prolonged rat model of UV-induced cataract]

Inhibitors of the Formation of Advanced Glycation End Products Based on Pyridoxine Azo Derivatives

Protective effect of amino acids on the stability of bayberry anthocyanins and the interaction mechanism between l-methionine and cyanidin-3-O-glycoside

Glycation-mediated inter-protein cross-linking is promoted by chaperone–client complexes of α-crystallin: Implications for lens aging and presbyopia

Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo